Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
European Review for Medical and Pharmacological Sciences|March 23, 2021
Low prevalence of SARS-CoV-2 infection in inflammatory bowel diseaseL Scucchi, B Neri, L Sarmati, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2006
Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantationV Cantaluppi, L Biancone, G Mauriello Romanazzi, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trialP Gionchetti, S Ardizzone, M E Benvenuti, et al.
Mucosal Immunology|July 13, 2012
IL-15 positively regulates IL-21 production in celiac disease mucosaM Sarra, M L Cupi, I Monteleone, et al.
Journal of Viral Hepatitis|February 7, 2013
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infectionF Morisco, F Castiglione, A Rispo, et al.
International Journal of Colorectal Disease|April 25, 2001
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.
European Review for Medical and Pharmacological Sciences|November 20, 2020
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trialA Orlando, F Mocciaro, M Ventimiglia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 12, 2005
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open studyA Orlando, E Colombo, A Kohn, et al.
Pageof 22